Chesnara To Buy MetLife's Closed-book UK Life Insurance Firm; Terms Not Disclosed
Chesnara plc (CSN.L) agreed to buy MetLife's (MET) closed-book UK life insurance unit, MetLife UK Limited, for an undisclosed sum. The deal, expected to close in early 2027, will add 18,000 policies and £1.7 billion in assets. Chesnara anticipates £45 million boost to Own Funds and Contractual Service Margin, with £90 million in lifetime cash flows, half within five years. Shares rose 1.15%.
How this was made
The 30-second read
Why it matters
The transaction is expected to be accretive for Chesnara, with modest cash‑flow benefits, while MetLife trims a non‑core asset.
Market read
First‑report M&A deal in the UK life insurance space; immediate price reaction for Chesnara and modest relevance for MetLife.
What to watch
Regulatory approval risk in the UK and potential cultural integration challenges could delay benefits.
Background
Chesnara is a consolidator of UK life insurers, seeking scale through acquisitions. MetLife is exiting its closed‑book UK operation.
Ticker impact
MetLife, Inc. is the seller of its closed‑book UK life insurance business in the announced transaction.
minimal impact; the sale is small relative to MetLife's overall balance sheet.
The UK closed‑book book is a modest portion of MetLife's total assets, and the terms were not disclosed.
Market effects
Consolidation trend in UK life insurance may spur further M&A activity in the sector.
Adds to the UK insurance market's M&A pipeline, potentially boosting related service providers.
Limited; primarily affects UK insurers and MetLife's balance sheet.
Counterpoint
The deal may be overpriced if integration costs exceed expectations, leading to future earnings pressure.
Key entities
- CompanyChesnara plc
UK life insurance and pensions consolidator acquiring MetLife UK.
- CompanyMetLife, Inc.
Seller of its closed‑book UK life insurance business.
